Searched for
LAGEVRIO
JN.1 Covid variant: Experts allay fears, cite low public health riskExperts advocate a balanced perspective while dealing with new variants of SARS-CoV-2. Lahariya stressed the importance of continued vigila...- Merck, Pfizer rebuff China's push for deeper price cuts on Covid drugsThe apparent rebuff coincides with a similar deadlock over Pfizer Inc's antiviral Paxlovid. Talks between the drugmaker and the Chinese age...
- Two choices for Covid patients - and a catchFor more such web stories click on the ET icon below.
- Covid pills are here, but they aren't for everyone. Find out if you should take this medicationThe pills have to be started as soon as possible, within five days of the start of symptoms.
- How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- UK approves Covid jab for under-12s as new daily cases top 100,000The developments came after the government said it was cutting the isolation period required for positive cases while Wales and Northern Ir...
- Dr. Reddy's open to making Pfizer COVID pill after Merck dealThe new drugs, which unlike vaccines can be used to treat patients once they contract coronavirus infection, are expected to be a huge mark...
- With UK nod, Merck drug becomes world's 1st pill for Covid treatmentThe MHRA recommended the use of Covid-19 drug molnupiravir as soon as possible following a positive Covid-19 test and within five days of s...
- UK drug regulatory approves COVID antiviral drug MolnupiravirThe risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease. MHRA recommended the use of Molnupiravir as s...
Load More
